Table 1.

Levels of pyrimidine and purine derivatives in the cells treated with myxothiazol, KCN or leflunomide

Treatment of the cells	Uridine (pmol/106 cells)	Cytidine (pmol/106 cells)	Guanosine (pmol/106 cells)	Adenosine (pmol/106 cells)
Control	4890 ± 222	1185 ± 51	2580 ± 56	8385 ± 225
KCN	4575 ± 333	960 ± 38	2835 ± 216	7290 ± 312
Leflunomide	1215 ± 77	285 ± 17	3540 ± 53	9705 ± 266
Myxothiazol	1260 ± 77	270 ± 3	3225 ± 141	7035 ± 62

RKO cells, control or treated with myxothiazol, KCN, or leflunomide were processed as described in Experimental Procedures. The experiments were performed in triplicates. Data are represented as mean ± SEM